Ignite Creation Date:
2024-05-06 @ 5:55 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05477160
Status:
COMPLETED
Last Update Posted:
2024-01-11
First Post:
2022-07-26
Brief Title:
A Study of STAR-0215 in Healthy Adult Participants
Sponsor:
Astria Therapeutics Inc
Organization:
Astria Therapeutics Inc
Study Overview
Official Title:
A First-in-Human Phase 1a Randomized Double-Blind Placebo Controlled Single Ascending Dose Study to Assess the Safety Tolerability Pharmacokinetics Pharmacodynamics and Immunogenicity of STAR-0215 in Healthy Adult Subjects
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a first-in-human single-center randomized double-blind placebo-controlled single ascending dose study evaluating the safety tolerability pharmacokinetics pharmacodynamics and immunogenicity of a single subcutaneous SC or intravenous IV administration of STAR-0215 in healthy adult participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None